Cellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1

TMEM16A Ca2+-activated Cl- channels (CaCC) control vital functions including arterial smooth muscle tone and blood flow. The TMEM16A has a pore with regions surrounding plasmalemmal lipids, an arrangement where lipids can directly influence the ion permeation and gating of the channel. Here, it is h...

Full description

Bibliographic Details
Main Author: Scofano, LF
Other Authors: Tammaro, P
Format: Thesis
Language:English
Published: 2022
_version_ 1797107670753214464
author Scofano, LF
author2 Tammaro, P
author_facet Tammaro, P
Scofano, LF
author_sort Scofano, LF
collection OXFORD
description TMEM16A Ca2+-activated Cl- channels (CaCC) control vital functions including arterial smooth muscle tone and blood flow. The TMEM16A has a pore with regions surrounding plasmalemmal lipids, an arrangement where lipids can directly influence the ion permeation and gating of the channel. Here, it is hypothesised that TMEM16A channel may serve as a lipid sensor and couple changes in lipid metabolism to changes in cell electrical activity. It is also argued that TMEM16A channels may be indirectly modulated by the lysosome and in particular by the lysosomal lipid transporter Niemann-Pick type C 1 (NPC1) protein, given the key involvement of this organelle in the control of plasmalemmal lipid composition. Thus, it is suggested that changes in the plasmalemmal composition driven by lysosomes, can modulate the plasma membrane-residing TMEM16A channel, impacting vascular function. Indeed loss-of-function mutations in NPC1 leads to Niemann-Pick disease Type C (NPC), a neurodegenerative disorder with a range of systemic alterations, including vascular. Here, I explore the capacity of the NPC1 to control TMEM16A function, and examine the consequence of this modulation on the tone of isolated arteries, which abundantly express TMEM16A. Key results include: (i) TMEM16A currents were enhanced during NPC1 inhibition; (ii) depletion of plasmalemmal phosphatidylinositol 4,5-biphosphate (PIP2) prevented this activation; (iii) plasmalemmal PIP2 distribution was increased during NPC1 inhibition; (iv) aortic rings and cerebral capillaries obtained from Npc1 null mice showed enhanced contractility; (v) β-cyclodextrin, a drug currently studied for treating NPC disease, prevented TMEM16A activation and aortic contractility in samples obtained from Npc1 null mice. These results indicate that TMEM16A activity is modulated by NPC1. This regulation affects the tone of arteries. PIP2-dependent changes in TMEM16A activity may be the basis of vascular overactivity associated with NPC disease.
first_indexed 2024-03-07T07:19:09Z
format Thesis
id oxford-uuid:f5354ad3-20fc-4e8a-9735-137d6539bfa6
institution University of Oxford
language English
last_indexed 2024-03-07T07:19:09Z
publishDate 2022
record_format dspace
spelling oxford-uuid:f5354ad3-20fc-4e8a-9735-137d6539bfa62022-09-09T16:17:53ZCellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1Thesishttp://purl.org/coar/resource_type/c_db06uuid:f5354ad3-20fc-4e8a-9735-137d6539bfa6EnglishHyrax Deposit2022Scofano, LFTammaro, PPlatt, FTMEM16A Ca2+-activated Cl- channels (CaCC) control vital functions including arterial smooth muscle tone and blood flow. The TMEM16A has a pore with regions surrounding plasmalemmal lipids, an arrangement where lipids can directly influence the ion permeation and gating of the channel. Here, it is hypothesised that TMEM16A channel may serve as a lipid sensor and couple changes in lipid metabolism to changes in cell electrical activity. It is also argued that TMEM16A channels may be indirectly modulated by the lysosome and in particular by the lysosomal lipid transporter Niemann-Pick type C 1 (NPC1) protein, given the key involvement of this organelle in the control of plasmalemmal lipid composition. Thus, it is suggested that changes in the plasmalemmal composition driven by lysosomes, can modulate the plasma membrane-residing TMEM16A channel, impacting vascular function. Indeed loss-of-function mutations in NPC1 leads to Niemann-Pick disease Type C (NPC), a neurodegenerative disorder with a range of systemic alterations, including vascular. Here, I explore the capacity of the NPC1 to control TMEM16A function, and examine the consequence of this modulation on the tone of isolated arteries, which abundantly express TMEM16A. Key results include: (i) TMEM16A currents were enhanced during NPC1 inhibition; (ii) depletion of plasmalemmal phosphatidylinositol 4,5-biphosphate (PIP2) prevented this activation; (iii) plasmalemmal PIP2 distribution was increased during NPC1 inhibition; (iv) aortic rings and cerebral capillaries obtained from Npc1 null mice showed enhanced contractility; (v) β-cyclodextrin, a drug currently studied for treating NPC disease, prevented TMEM16A activation and aortic contractility in samples obtained from Npc1 null mice. These results indicate that TMEM16A activity is modulated by NPC1. This regulation affects the tone of arteries. PIP2-dependent changes in TMEM16A activity may be the basis of vascular overactivity associated with NPC disease.
spellingShingle Scofano, LF
Cellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1
title Cellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1
title_full Cellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1
title_fullStr Cellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1
title_full_unstemmed Cellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1
title_short Cellular and molecular pharmacology of the lipid-sensitive channel TMEM16A/Anoctamin1
title_sort cellular and molecular pharmacology of the lipid sensitive channel tmem16a anoctamin1
work_keys_str_mv AT scofanolf cellularandmolecularpharmacologyofthelipidsensitivechanneltmem16aanoctamin1